Comparable stake leader
Accelmed Partners II L.P.
SEC ownership of MINERVA SURGICAL INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001452965.
Disclosed value leader
Accelmed Partners II L.P.
Comparable rows
0/16
Latest evidence
01 Mar 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Accelmed Partners II L.P.
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
01 Mar 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001452965
- Issuer location
- Santa Clara, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of MINERVA SURGICAL INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Accelmed Partners II L.P.
Disclosed value leader
Accelmed Partners II L.P.
Comparable rows
0/16
Latest evidence
01 Mar 2023
3/4/5
Highest disclosed value: $25,000,000
16 rows are not safely comparable across share classes.
Showing 1-8 of 16 holder rows.
Quick read
Accelmed Partners II L.P. has the largest disclosed position value at $25M.
0 of 16 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Accelmed Partners II L.P.'s linked filing trail.
Disclosed position value
Top 5
Accelmed Partners II L.P.
$25M
Uri Geiger
$25M
NEW ENTERPRISE ASSOCIATES 13 LP
$7.05M
Novo Holdings A/S
$420.9K
Daniel Cohen
$25M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 16 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Accelmed Partners II L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$25,000,000
122,189,638 shares
|
— | 09 Feb 2023 |
| Uri Geiger |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$25,000,000
122,189,638 shares
|
— | 09 Feb 2023 |
| NEW ENTERPRISE ASSOCIATES 13 LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$7,045,821
34,437,052 shares
|
— | 09 Feb 2023 |
| Novo Holdings A/S |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$420,889
2,057,132 shares
|
— | 26 Oct 2021 |
| Daniel Cohen |
3/4/5
Director
|
—
class O/S missing
|
$25,000,000
122,189,638 shares
|
— | 01 Mar 2023 |
| David M. Clapper |
3/4/5
President and CEO, Director
|
—
class O/S missing
|
$197,621
965,892 shares
|
— | 02 May 2022 |
| Dominique J. Filloux |
3/4/5
COO
|
—
class O/S missing
|
$54,483
266,289 shares
|
— | 02 May 2022 |
| Evgueni V Skalnyi |
3/4/5
VP Medical Affairs
|
—
class O/S missing
|
$50,071
244,725 shares
|
— | 02 May 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 08 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to MINERVA SURGICAL INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Daniel Cohen
Net 12M change
$0
Latest report
01 Mar 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Daniel Cohen | Director | $25,000,000 | Mixed | 01 Mar 2023 | ||
| Uri Geiger | Director, 10%+ Owner | $25,000,000 | Mixed | 09 Feb 2023 | ||
| Accelmed Partners II L.P. | 10%+ Owner | $25,000,000 | Mixed | 09 Feb 2023 | ||
| NEW ENTERPRISE ASSOCIATES 13 LP | 10%+ Owner | $7,045,821 | Filing P/S | 09 Feb 2023 | ||
| Novo Holdings A/S | 10%+ Owner | $420,889 | Mixed | 26 Oct 2021 | ||
| David M. Clapper | President and CEO, Director | $197,621 | Mixed | 02 May 2022 | ||
| Dominique J. Filloux | Coo | $54,483 | Mixed | 02 May 2022 | ||
| Evgueni V Skalnyi | VP Medical Affairs | $50,071 | Mixed | 02 May 2022 | ||
| Joel R. Jung | Cfo | $45,161 | Mixed | 02 May 2022 | ||
| Ross A. Jaffe MD | Director | $29,574 | Mixed | 10 Jun 2022 | ||
| Catherine Coste | Director | $26,512 | Mixed | 10 Jun 2022 | ||
| Derrick Sung | Director | $17,791 | Mixed | 19 Jul 2022 | ||
| Ali Behbahani | Director | $11,924 | Mixed | 10 Jun 2022 | ||
| David Renzi | Director | $10,187 | Mixed | 10 Jun 2022 | ||
| Niquette L. Hunt | Director | $10,187 | Mixed | 10 Jun 2022 | ||
| Jill Anderson | Director | $10,187 | Mixed | 10 Jun 2022 | ||
| Todd Usen | Chief Executive Officer, Director | Mixed | 02 Jan 2023 |
Recent insider transactions for MINERVA SURGICAL INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.